SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver
Status:
Withdrawn
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Randomized phase I trial to compare the effectiveness of different doses of SCH
66336 before surgery in treating patients who have colorectal cancer that has metastasized to
the liver.